Cardiac Science buys defibrillator company:
This article was originally published in Clinica
Cardiac Science, of Irvine, California, is to buy private R&D company HeartSine Technologies, which is developing defibrillator systems. Cardiac will issue one million shares. HeartSine, which has operations in Northern Ireland and Orange Country, California, is focused on defibrillation waveforms, cardiac arrhythmia detection algorithms and cardiac pacing. Cardiac Science says HeartSine's technologies will accelerate the integration of Cardiac's RHYTHMx ECD automatic cardiac arrest detection and treatment module into standard bedside monitoring systems.